BUNGE GLOBAL SA (BG) Fundamental Analysis & Valuation

NYSE:BG • CH1300646267

Current stock price

123.92 USD
+0.96 (+0.78%)
At close:
123.92 USD
0 (0%)
After Hours:

This BG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. BG Profitability Analysis

1.1 Basic Checks

  • In the past year BG was profitable.
  • BG had a positive operating cash flow in the past year.
  • Each year in the past 5 years BG has been profitable.
  • In multiple years BG reported negative operating cash flow during the last 5 years.
BG Yearly Net Income VS EBIT VS OCF VS FCFBG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B -4B -6B

1.2 Ratios

  • BG has a Return On Assets (1.83%) which is in line with its industry peers.
  • With a Return On Equity value of 5.13%, BG perfoms like the industry average, outperforming 53.49% of the companies in the same industry.
  • BG has a Return On Invested Capital (3.48%) which is in line with its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BG is in line with the industry average of 6.80%.
  • The 3 year average ROIC (7.86%) for BG is well above the current ROIC(3.48%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.83%
ROE 5.13%
ROIC 3.48%
ROA(3y)5.08%
ROA(5y)6.07%
ROE(3y)12.06%
ROE(5y)16.06%
ROIC(3y)7.86%
ROIC(5y)9.39%
BG Yearly ROA, ROE, ROICBG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20

1.3 Margins

  • BG has a Profit Margin of 1.16%. This is comparable to the rest of the industry: BG outperforms 46.51% of its industry peers.
  • In the last couple of years the Profit Margin of BG has declined.
  • BG has a Operating Margin of 2.18%. This is comparable to the rest of the industry: BG outperforms 48.84% of its industry peers.
  • BG's Operating Margin has declined in the last couple of years.
  • BG has a worse Gross Margin (4.85%) than 76.74% of its industry peers.
  • BG's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.18%
PM (TTM) 1.16%
GM 4.85%
OM growth 3Y-15.13%
OM growth 5Y-8.6%
PM growth 3Y-21.46%
PM growth 5Y-15.59%
GM growth 3Y-4.88%
GM growth 5Y-6.34%
BG Yearly Profit, Operating, Gross MarginsBG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 4 6 8

2

2. BG Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BG is still creating some value.
  • The number of shares outstanding for BG has been increased compared to 1 year ago.
  • Compared to 5 years ago, BG has more shares outstanding
  • The debt/assets ratio for BG is higher compared to a year ago.
BG Yearly Shares OutstandingBG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
BG Yearly Total Debt VS Total AssetsBG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

  • BG has an Altman-Z score of 2.85. This is not the best score and indicates that BG is in the grey zone with still only limited risk for bankruptcy at the moment.
  • BG's Altman-Z score of 2.85 is fine compared to the rest of the industry. BG outperforms 67.44% of its industry peers.
  • BG has a Debt/Equity ratio of 0.81. This is a neutral value indicating BG is somewhat dependend on debt financing.
  • BG has a Debt to Equity ratio of 0.81. This is in the lower half of the industry: BG underperforms 60.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Altman-Z 2.85
ROIC/WACC0.46
WACC7.59%
BG Yearly LT Debt VS Equity VS FCFBG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B 15B

2.3 Liquidity

  • A Current Ratio of 1.61 indicates that BG should not have too much problems paying its short term obligations.
  • The Current ratio of BG (1.61) is comparable to the rest of the industry.
  • BG has a Quick Ratio of 1.61. This is a bad value and indicates that BG is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BG's Quick ratio of 0.74 is on the low side compared to the rest of the industry. BG is outperformed by 60.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 0.74
BG Yearly Current Assets VS Current LiabilitesBG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

6

3. BG Growth Analysis

3.1 Past

  • The earnings per share for BG have decreased strongly by -19.70% in the last year.
  • Measured over the past years, BG shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.75% on average per year.
  • BG shows a strong growth in Revenue. In the last year, the Revenue has grown by 32.43%.
  • The Revenue has been growing by 11.18% on average over the past years. This is quite good.
EPS 1Y (TTM)-19.7%
EPS 3Y-19.06%
EPS 5Y-1.75%
EPS Q2Q%-6.57%
Revenue 1Y (TTM)32.43%
Revenue growth 3Y1.51%
Revenue growth 5Y11.18%
Sales Q2Q%75.47%

3.2 Future

  • BG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.59% yearly.
  • Based on estimates for the next years, BG will show a quite strong growth in Revenue. The Revenue will grow by 11.87% on average per year.
EPS Next Y13.41%
EPS Next 2Y18.33%
EPS Next 3Y13.59%
EPS Next 5YN/A
Revenue Next Year32.32%
Revenue Next 2Y18.24%
Revenue Next 3Y11.87%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BG Yearly Revenue VS EstimatesBG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20B 40B 60B 80B
BG Yearly EPS VS EstimatesBG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10

4

4. BG Valuation Analysis

4.1 Price/Earnings Ratio

  • BG is valuated correctly with a Price/Earnings ratio of 16.79.
  • 63.95% of the companies in the same industry are more expensive than BG, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 26.78. BG is valued slightly cheaper when compared to this.
  • A Price/Forward Earnings ratio of 14.81 indicates a correct valuation of BG.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BG indicates a somewhat cheap valuation: BG is cheaper than 70.93% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.54. BG is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 16.79
Fwd PE 14.81
BG Price Earnings VS Forward Price EarningsBG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BG is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.96
BG Per share dataBG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200 300

4.3 Compensation for Growth

  • BG's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • BG's earnings are expected to grow with 13.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.25
PEG (5Y)N/A
EPS Next 2Y18.33%
EPS Next 3Y13.59%

6

5. BG Dividend Analysis

5.1 Amount

  • BG has a Yearly Dividend Yield of 2.18%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 2.24, BG pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, BG has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.18%

5.2 History

  • The dividend of BG has a limited annual growth rate of 3.41%.
  • BG has paid a dividend for at least 10 years, which is a reliable track record.
  • BG has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)3.41%
Div Incr Years5
Div Non Decr Years24
BG Yearly Dividends per shareBG Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • BG pays out 56.25% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • The dividend of BG is growing, but earnings are growing more, so the dividend growth is sustainable.
DP56.25%
EPS Next 2Y18.33%
EPS Next 3Y13.59%
BG Yearly Income VS Free CF VS DividendBG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B -4B -6B
BG Dividend Payout.BG Dividend Payout, showing the Payout Ratio.BG Dividend Payout.PayoutRetained Earnings

BG Fundamentals: All Metrics, Ratios and Statistics

BUNGE GLOBAL SA

NYSE:BG (4/10/2026, 8:07:43 PM)

After market: 123.92 0 (0%)

123.92

+0.96 (+0.78%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-04
Earnings (Next)05-05
Inst Owners76.8%
Inst Owner Change0%
Ins Owners0.75%
Ins Owner Change2.27%
Market Cap23.98B
Revenue(TTM)70.33B
Net Income(TTM)816.00M
Analysts83.81
Price Target133.82 (7.99%)
Short Float %3.46%
Short Ratio2.97
Dividend
Industry RankSector Rank
Dividend Yield 2.18%
Yearly Dividend2.81
Dividend Growth(5Y)3.41%
DP56.25%
Div Incr Years5
Div Non Decr Years24
Ex-Date05-22
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.87%
Min EPS beat(2)5.28%
Max EPS beat(2)6.46%
EPS beat(4)4
Avg EPS beat(4)14.73%
Min EPS beat(4)5.28%
Max EPS beat(4)35.7%
EPS beat(8)6
Avg EPS beat(8)8.09%
EPS beat(12)9
Avg EPS beat(12)11.75%
EPS beat(16)11
Avg EPS beat(16)12.63%
Revenue beat(2)2
Avg Revenue beat(2)4.51%
Min Revenue beat(2)1.7%
Max Revenue beat(2)7.32%
Revenue beat(4)2
Avg Revenue beat(4)-4.41%
Min Revenue beat(4)-18.75%
Max Revenue beat(4)7.32%
Revenue beat(8)2
Avg Revenue beat(8)-4.94%
Revenue beat(12)3
Avg Revenue beat(12)-5.27%
Revenue beat(16)5
Avg Revenue beat(16)-4.68%
PT rev (1m)0.75%
PT rev (3m)21.53%
EPS NQ rev (1m)2.83%
EPS NQ rev (3m)-55.71%
EPS NY rev (1m)-6.71%
EPS NY rev (3m)-6.26%
Revenue NQ rev (1m)-1.01%
Revenue NQ rev (3m)6.12%
Revenue NY rev (1m)-1.34%
Revenue NY rev (3m)8.62%
Valuation
Industry RankSector Rank
PE 16.79
Fwd PE 14.81
P/S 0.34
P/FCF N/A
P/OCF 28.41
P/B 1.51
P/tB 1.93
EV/EBITDA 12.96
EPS(TTM)7.38
EY5.96%
EPS(NY)8.37
Fwd EY6.75%
FCF(TTM)-4.54
FCFYN/A
OCF(TTM)4.36
OCFY3.52%
SpS363.44
BVpS82.19
TBVpS64.36
PEG (NY)1.25
PEG (5Y)N/A
Graham Number116.82
Profitability
Industry RankSector Rank
ROA 1.83%
ROE 5.13%
ROCE 5.21%
ROIC 3.48%
ROICexc 3.83%
ROICexgc 4.32%
OM 2.18%
PM (TTM) 1.16%
GM 4.85%
FCFM N/A
ROA(3y)5.08%
ROA(5y)6.07%
ROE(3y)12.06%
ROE(5y)16.06%
ROIC(3y)7.86%
ROIC(5y)9.39%
ROICexc(3y)9.45%
ROICexc(5y)11.04%
ROICexgc(3y)10.1%
ROICexgc(5y)11.8%
ROCE(3y)10.97%
ROCE(5y)12.98%
ROICexgc growth 3Y-33.02%
ROICexgc growth 5Y-12.38%
ROICexc growth 3Y-34.28%
ROICexc growth 5Y-13.03%
OM growth 3Y-15.13%
OM growth 5Y-8.6%
PM growth 3Y-21.46%
PM growth 5Y-15.59%
GM growth 3Y-4.88%
GM growth 5Y-6.34%
F-Score4
Asset Turnover1.58
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Debt/EBITDA 5.78
Cap/Depr 245.09%
Cap/Sales 2.45%
Interest Coverage 2.73
Cash Conversion 37.75%
Profit Quality N/A
Current Ratio 1.61
Quick Ratio 0.74
Altman-Z 2.85
F-Score4
WACC7.59%
ROIC/WACC0.46
Cap/Depr(3y)262.63%
Cap/Depr(5y)203.61%
Cap/Sales(3y)2.31%
Cap/Sales(5y)1.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.7%
EPS 3Y-19.06%
EPS 5Y-1.75%
EPS Q2Q%-6.57%
EPS Next Y13.41%
EPS Next 2Y18.33%
EPS Next 3Y13.59%
EPS Next 5YN/A
Revenue 1Y (TTM)32.43%
Revenue growth 3Y1.51%
Revenue growth 5Y11.18%
Sales Q2Q%75.47%
Revenue Next Year32.32%
Revenue Next 2Y18.24%
Revenue Next 3Y11.87%
Revenue Next 5YN/A
EBIT growth 1Y-14.93%
EBIT growth 3Y-13.85%
EBIT growth 5Y1.61%
EBIT Next Year82%
EBIT Next 3Y28.59%
EBIT Next 5YN/A
FCF growth 1Y-267.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-55.58%
OCF growth 3YN/A
OCF growth 5YN/A

BUNGE GLOBAL SA / BG Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BUNGE GLOBAL SA?

ChartMill assigns a fundamental rating of 4 / 10 to BG.


What is the valuation status for BG stock?

ChartMill assigns a valuation rating of 4 / 10 to BUNGE GLOBAL SA (BG). This can be considered as Fairly Valued.


How profitable is BUNGE GLOBAL SA (BG) stock?

BUNGE GLOBAL SA (BG) has a profitability rating of 4 / 10.


Can you provide the financial health for BG stock?

The financial health rating of BUNGE GLOBAL SA (BG) is 2 / 10.


Can you provide the expected EPS growth for BG stock?

The Earnings per Share (EPS) of BUNGE GLOBAL SA (BG) is expected to grow by 13.41% in the next year.